InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (19 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
19
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Stuelpnagel John R, Chairman of the Board. Officer active across 1 company, notably 10x Genomics, Inc.. Cumulatively, 25 filings have been published. Split: 0 buy · 19 sells. Total volume traded: €4.6m. Activity tracked since 3 May 2021. The latest transaction was disclosed on 11 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Stuelpnagel John R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
17,000 shares@ US$57.5812Class A Common StockSEC:0001610717-26-000358:0
3,000 shares@ US$58.725Class A Common StockSEC:0001610717-26-000358:1
8,829 shares0Class A Common StockSEC:0001610717-26-000194:0
15,357 shares0Class A Common StockSEC:0001610717-25-000170:0
8,649 shares0Class A Common StockSEC:0001610717-24-000330:0
1,865 shares0Class A Common StockSEC:0001610717-23-000175:0
10,000 shares@ US$54.88947.6% of flowClass A Common StockSEC:0001610717-23-000099:0
2,120 shares0Class A Common StockSEC:0001567619-22-013121:0
3,218 shares@ US$150.559611.8% of flowClass A Common StockSEC:0001567619-22-000366:0
2,000 shares@ US$150.51087.4% of flowClass A Common StockSEC:0001567619-21-021614:0
800 shares@ US$157.54813.1% of flowClass A Common StockSEC:0001567619-21-020783:0
100 shares@ US$160.330.4% of flowClass A Common StockSEC:0001567619-21-019298:0
4,400 shares@ US$150.513615.8% of flowClass A Common StockSEC:0001567619-21-018503:0
5,000 shares@ US$150.179818.0% of flowClass A Common StockSEC:0001567619-21-018209:0
700 shares@ US$154.45292.5% of flowClass A Common StockSEC:0001209191-21-056956:0
300 shares@ US$175.35831.2% of flowClass A Common StockSEC:0001209191-21-054901:0
300 shares@ US$157.31331.1% of flowClass A Common StockSEC:0001209191-21-052383:0
1,100 shares@ US$178.47594.6% of flowClass A Common StockSEC:0001209191-21-049653:0
500 shares@ US$168.5652.0% of flowClass A Common StockSEC:0001209191-21-047362:0
1,600 shares@ US$189.9437.1% of flowClass A Common StockSEC:0001209191-21-045480:0
100 shares@ US$190.970.4% of flowClass A Common StockSEC:0001209191-21-042115:0
625 shares0Class A Common StockSEC:0001209191-21-040695:0
1,597 shares@ US$171.58296.2% of flowClass A Common StockSEC:0001209191-21-037904:0
500 shares@ US$139.58651.6% of flowClass A Common StockSEC:0001209191-21-034132:0
600 shares@ US$189.25122.6% of flowClass A Common StockSEC:0001209191-21-030399:0
25 of 25 declarations
About Stuelpnagel John R
STUELPNAGEL JOHN R is Chairman of the Board and has 23 filings in total. In the most recent filings held, all transactions are sales, totaling EUR 3610624 between 2021-05-05 and 2026-06-08, involving 10x Genomics, Inc., where he is a Director.
